Search Results 351-360 of 18215 for total bilirubin

1. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

   Total abstinence when this is in line with the preferred and usual lifestyle ... bilirubin ≥ 1.5 x ULN; hemoglobin < 10 g/dL (100.0 g/L); total white ...

2. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 times upper limit of normal (ULN). For total bilirubin > 1.5 times ULN, the direct bilirubin must be normal. Alkaline phosphatase ≤ 3 ...

3. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) - Mayo Clinic

   Liver function: total bilirubin < 1.5 x the upper limit of normal and ... serum bilirubin and diarrhea. Standard criteria have been developed and used ...

4. Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia - Mayo Clinic

   Serum direct bilirubin < 2 mg/dl or serum total bilirubin ≤ 3; NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction ...

5. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   - Total bilirubin =< 1.0 x upper limit of normal (ULN) or direct bilirubin within the institutional normal range for patients with Gilbert's syndrome

6. Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis - Mayo Clinic

   Screening total bilirubin >2x ULN. Total bilirubin >2x ULN is acceptable if bilirubin is fractionated and direct bilirubin <35%. Screening ALT or AST >6x ...

7. CraniSeal Post Approval Study - Mayo Clinic

   * Patient with diagnosis of severely altered renal (creatinine levels \> 2.0 mg/dL) or hepatic (total bilirubin \> 2.5 mg/dL) function. * Patient diagnosed ...

8. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Hepatic impairment defined as: Total bilirubin ≥ 2 × the upper limit of normal (ULN); or; Aspartate aminotransferase (AST) ≥ 5 × ULN; or; Alanine ...

9. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

   ... total bilirubin > 2 × ULN as long as direct bilirubin is ≤ 1.5 × ULN) * Current or chronic history of liver disease that is considered clinically ...

10. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    - Total bilirubin ≤1.5 ×ULN OR direct bilirubin ≤ULN for participants with total bilirubin levels >1.5 × ULN - AST (SGOT) and ALT (SGPT) ≤2.5 × ULN